Astrana Health, Inc. Reports Fourth Quarter and Year-End 2024 Results

Core Insights - Astrana Health, Inc. reported strong financial performance for the year ended December 31, 2024, with total revenue of $2,034.5 million, representing a 47$1,386.7 million in 2023 [9] - The company emphasized its commitment to patient-centered care and geographic expansion as key drivers of growth [2][3] Financial Highlights - Total revenue for the fourth quarter of 2024 was $665.2 million, an 88$353.0 million in the same quarter of 2023 [9] - Care Partners revenue reached $1,949.0 million for the year, up 52$1,284.1 million in 2023 [9] - Net income attributable to Astrana for the year was $43.1 million, down from$60.7 million in 2023, with diluted earnings per share of $0.90 compared to$1.29 [9] - Adjusted EBITDA for the year was $170.4 million, a 16$146.6 million in 2023 [9] Recent Developments - Astrana initiated a Care Enablement partnership with Provider HealthLink to support approximately 10,000 Medicare Advantage members [9] - The company amended its credit agreement with Truist Bank, establishing a five-year revolving credit facility of $300 million and a five-year term loan A credit facility of$250 million [9] - Eight affiliates of Astrana were recognized as Elite status recipients in the 2024 Standards of Excellence survey by America's Physician Groups [9] Segment Results - Care Partners segment generated revenues of $1,949.0 million, with a 52$136.7 million, up 16% from the previous year [12] - The Care Enablement segment achieved revenues of $155.4 million, reflecting a 14$2,500 million and $2,700 million, and Adjusted EBITDA between$170 million and $190 million [14][15]